As expected, Sanofi-Aventis (NASDAQ:SNY) agrees to buy Merck's (NYSE:MRK) half of their Merial...Jul. 30, 2009 7:32 AM ETSanofi (SNY) StockMRK, SNY, SGPBy: Rachael Granby, SA News Editor As expected, Sanofi-Aventis (NASDAQ:SNY) agrees to buy Merck's (NYSE:MRK) half of their Merial animal-health JV for $4B in cash. The deal should help Merck allay antitrust concerns over its proposed purchase of Schering-Plough (SGP). Recommended For YouCommentsNewestPublishHave a tip? Submit confidentially to our News team. Found a factual error? Report here.More Trending NewsCatalyst Watch: Intel's AI event, Oracle earnings and CAVA IPO lockup expirationRecord-breaking U.S. supply is weighing on the global oil marketTop 10 best performing energy stocks of 2023Spirit/JetBlue court decision likely to come early next year - reportTaiwan Semiconductor sales plunge in NovemberSee More »About SNYSymbolLast Price% Chg1D5D1M6M1Y5Y10YMarket CapPEYield (TTM)Rev Growth (YoY)Short InterestPrev. CloseCompare to PeersRelated StocksSymbolLast Price% ChgSNY--SanofiBMY--Bristol-Myers Squibb CompanyZTS--Zoetis Inc.GSK--GSK plcPFE--Pfizer Inc.CompareTrending AnalysisTrending News